Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population
- PMID: 7543776
- DOI: 10.1021/bi00032a005
Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population
Abstract
Most peptides that bind to a particular MHC class I molecule share amino acid residues that are thought to physically "anchor" the peptide to polymorphic pockets within the class I binding site. Sequence analysis of endogenous peptides bound to HLA-B44 revealed two potential dominant anchor residues: Glu at P2 and Tyr, or occasionally Phe, at P9. In vitro assembly assays employing synthetic peptides and recombinant HLA-B44 produced by Escherichia coli revealed that an acidic amino acid at P2 was necessary for promoting stable peptide binding to HLA-B44. Surprisingly, although Tyr was almost exclusively found at P9 of the endogenous peptide sequences, a wide variety of amino acid residues such as Leu, Ala, Arg, Lys, His, and Phe could be tolerated at this position. Using this information, we identified antigenic peptides from the influenza virus components nonstructural protein 1 and nucleoprotein that are presented by HLA-B44 to antiinfluenza type A cytotoxic T lymphocytes. In addition, cytotoxic T lymphocytes induced by these antigenic peptides were shown to be capable of recognizing endogenously processed peptides from influenza-infected cells, indicating a potential use for these peptides in vaccine development. Finally, molecular models were created to investigate the possible ways in which the anchor residues might function to stabilize the binding of peptides to HLA-B44, and these models indicate that the acidic residue at P2 most likely interacts primarily with Lys 45 of the HLA-B44 heavy chain and makes additional contacts with Ser 67 and Tyr 9.
Similar articles
-
The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor residues.J Biol Chem. 1994 Dec 23;269(51):32426-34. J Biol Chem. 1994. PMID: 7528217
-
Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex.FEBS Lett. 2002 Sep 11;527(1-3):27-32. doi: 10.1016/s0014-5793(02)03149-6. FEBS Lett. 2002. PMID: 12220628
-
Differences in the recognition by CTL of peptides presented by the HLA-B*4402 and the HLA-B*4403 molecules which differ by a single amino acid.Tissue Antigens. 1999 Feb;53(2):111-21. doi: 10.1034/j.1399-0039.1999.530201.x. Tissue Antigens. 1999. PMID: 10090611
-
Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain.Tissue Antigens. 1994 Nov;44(5):311-7. doi: 10.1111/j.1399-0039.1994.tb02401.x. Tissue Antigens. 1994. PMID: 7878657
-
Class I MHC-peptide interaction: structural and functional aspects.Behring Inst Mitt. 1994 Jul;(94):48-60. Behring Inst Mitt. 1994. PMID: 7998914 Review.
Cited by
-
Epistatically interacting substitutions are enriched during adaptive protein evolution.PLoS Genet. 2014 May 8;10(5):e1004328. doi: 10.1371/journal.pgen.1004328. eCollection 2014 May. PLoS Genet. 2014. PMID: 24811236 Free PMC article.
-
A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.Immunogenetics. 1996;43(6):377-83. doi: 10.1007/BF02199806. Immunogenetics. 1996. PMID: 8606058
-
A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition.J Exp Med. 2003 Sep 1;198(5):679-91. doi: 10.1084/jem.20030066. Epub 2003 Aug 25. J Exp Med. 2003. PMID: 12939341 Free PMC article.
-
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.Science. 2018 Feb 2;359(6375):582-587. doi: 10.1126/science.aao4572. Epub 2017 Dec 7. Science. 2018. PMID: 29217585 Free PMC article.
-
Evidence of focusing the MHC class I immunopeptidome by tapasin.Front Immunol. 2025 May 8;16:1563789. doi: 10.3389/fimmu.2025.1563789. eCollection 2025. Front Immunol. 2025. PMID: 40406141 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials